We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreNew process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read moreNICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreA cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...
Read moreOur research is aimed at identifying trends in terminated appraisals in relation to therapeutic area...
Read moreNICE provided more detail into how the process will work, with the early value assessments providing...
Read moreThe HTA initially recommended Tremfya as a treatment option for adults with active psoriatic arthrit...
Read moreNICE have been clear that this framework should not be interpreted as minimum standards for real-wor...
Read more